Molecular definition of vaginal microbiota in east african commercial sex workers

Applied and Environmental Microbiology

Volumn 77, Issue 12, 2011, Pages 4066-4074

  Schellenberg, John J ^a   Links, Matthew G ^b,c   Hill, Janet E ^c   Dumonceaux, Tim J ^b   Kimani, Joshua ^d   Jaoko, Walter ^d   Wachihi, Charles ^d   Mungai, Jane Njeri ^d   Peters, Geoffrey A ^e   Tyler, Shaun ^e   Graham, Morag ^e   Severini, Alberto ^e   Fowke, Keith R ^a   Ball, T Blake ^a,e   Plummer, Francis A ^a,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SASKATOON RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; BETAPROTEOBACTERIA; CHAPERONIN; EAST AFRICANS; HIV INFECTION; INITIAL HYPOTHESIS; LOW LEVEL; MICROBIAL COMMUNITIES; MICROBIOTAS; MOLECULAR DEFINITIONS; MOLECULAR LEVELS; MUCOSAL IMMUNITY; NAIROBI , KENYA; PHYLOGENETIC PROFILE; RISK FACTORS; VARIOVORAX PARADOXUS;

ESCHERICHIA COLI;

MICROORGANISMS;

CHAPERONIN;

ABUNDANCE; BACTERIUM; DISEASE RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; MICROBIAL COMMUNITY; MICROBIOLOGY; MOLECULAR ANALYSIS; MUCUS; PH; PHYLOGENETICS; PROSTITUTION; RISK FACTOR; SECONDARY SEXUAL CHARACTERISTICS; WOMENS HEALTH;

ARTICLE; BACTERIUM; BIODIVERSITY; CLASSIFICATION; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MICROBIOLOGY; PROSTITUTION; VAGINA;

BACTERIA; BIODIVERSITY; CHAPERONIN 60; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HUMANS; KENYA; PROSTITUTION; VAGINA;

KENYA; NAIROBI [KENYA];

BACTERIA (MICROORGANISMS); BETAPROTEOBACTERIA; ESCHERICHIA COLI; GARDNERELLA; LACTOBACILLUS; VARIOVORAX PARADOXUS;

EID: 79960108637     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02943-10     Document Type: Article

References (59)

1. Ahmed, N., et al. 2010. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. J. Gen. Virol. 91:2804-2813.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Amsel, R., et al. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22.
4. Anesti, V., et al. 2005. Isolation and molecular detection of methylotrophic bacteria occurring in the human mouth. Environ. Microbiol. 7:1227-1238.
5. Atashili, J., C. Poole, P. M. Ndumbe, A. A. Adimora, and J. S. Smith. 2008. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22:1493-1501.
6. Ball, T. B., et al. 2007. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21:1091-1101.
7. 2-producing Lactobacillus among women with bacterial vaginosis. J. Infect. Dis. 191:924-929.
8. Bonfield, J. K., K. Smith, and R. Staden. 1995. A new DNA sequence assembly program. Nucleic Acids Res. 23:4992-4999.
9. Boskey, E. R., K. M. Telsch, K. J. Whaley, T. R. Moench, and R. A. Cone. 1999. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 67:5170-5175.
10. Braat, H., et al. 2004. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 80:1618-1625.
11. Burgener, A., et al. 2008. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J. Proteome Res. 7:4446-4454.
12. Card, C. M., et al. 2009. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+) FOXP3(+) regulatory T cells. J. Infect. Dis. 199:1318-1322.
13. Cauci, S., R. Monte, S. Driussi, P. Lanzafame, and F. Quadrifoglio. 1998. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. J. Infect. Dis. 178:1698-1706.
14. Dethlefsen, L., M. McFall-Ngai, and D. A. Relman. 2007. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811-818.
15. Donachie, S. P., J. S. Foster, and M. V. Brown. 2007. Culture clash: challenging the dogma of microbial diversity. ISME J. 1:97-99.
16. Dumonceaux, T. J., et al. 2006. Enumeration of specific bacterial populations in complex intestinal communities using quantitative PCR based on the chaperonin-60 target. J. Microbiol. Methods 64:46-62.
17. Dumonceaux, T. J., et al. 2009. Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres. J. Clin. Microbiol. 47: 4067-4077.
18. Fleming, D. T., and J. N. Wasserheit. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75:3-17.
19. Fowke, K. R., et al. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347-1351.
20. Goh, S. H., et al. 1996. HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci. J. Clin. Microbiol. 34:818-823.
21. Goldenberg, R. L., J. F. Culhane, J. D. Iams, and R. Romero. 2008. Epidemiology and causes of preterm birth. Lancet 371:75-84.
22. Gottlieb, M. S., et al. 1981. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:1425-1431.
23. Haase, A. T. 2005. Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5:783-792.
24. Harwich, M. D., Jr, et al. 2010. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics 11:375.
25. Hill, J. E., et al. 2005. Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am. J. Obstet. Gynecol. 193:682-692.
26. Hill, J. E., et al. 2006. Identification of Campylobacter spp. and discrimination from Helicobacter and Arcobacter spp. by direct sequencing of PCRamplified cpn60 sequences and comparison to cpnDB, a chaperonin reference sequence database. J. Med. Microbiol. 55:393-399.
27. Hill, J. E., S. L. Penny, K. G. Crowell, S. H. Goh, and S. M. Hemmingsen. 2004. cpnDB: a chaperonin sequence database. Genome Res. 14:1669-1675.
28. Hillier, S. L. 1998. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retroviruses 14(Suppl. 1):S17-S21.
29. Hummelen, R., et al. 2010. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5:e12078.
30. Iqbal, S. M., et al. 2009. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 23:1669-1677.
31. Kaul, R., et al. 2001. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J. Clin. Invest. 107:341-349.
32. Larsson, P. G., et al. 2005. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS 113:233-245.
33. Lin, P. W., et al. 2009. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic. Biol. Med. 47:1205-1211.
34. Ling, Z., et al. 2010. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 11:488.
35. Livengood, C. H. 2009. Bacterial vaginosis: an overview for 2009. Rev. Obstet. Gynecol. 2:28-37.
36. Lozupone, C., M. Hamady, and R. Knight. 2006. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7:371.
37. Lozupone, C., and R. Knight. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71:8228-8235.
38. MacDonald, K. S., et al. 2000. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J. Infect. Dis. 181:1581-1589.
39. Milne, I., et al. 2010. Tablet-next generation sequence assembly visualization. Bioinformatics 26:401-402.
40. Mitchell, C. M., et al. 2008. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res. Hum. Retroviruses 24:667-671.
41. Nugent, R. P., M. A. Krohn, and S. L. Hillier. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29:297-301.
42. Pearson, W. R., and D. J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U. S. A. 85:2444-2448.
43. Piot, P., et al. 1984. Biotypes of Gardnerella vaginalis. J. Clin. Microbiol. 20:677-679.
44. Pybus, V., and A. B. Onderdonk. 1997. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J. Infect. Dis. 175: 406-413.
45. Rabe, L. K., and S. L. Hillier. 2003. Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J. Clin. Microbiol. 41:3260-3264.
46. Ravel, J., et al. 2010. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U. S. A. http://www.pnas.org/content/early/2010/06/02/1002611107.full.pdf.
47. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
48. Schellenberg, J. 2010. The microbiological context of HIV resistance. Ph.D. thesis. University of Manitoba, Winnipeg, Manitoba, Canada. http://hdl.handle.net/1993/4022.
49. Schellenberg, J., et al. 2009. Pyrosequencing of the chaperonin-60 universal target as a tool for determining microbial community composition. Appl. Environ. Microbiol. 75:2889-2898.
50. Schloss, P. D., et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537-7541.
51. Spear, G. T., et al. 2008. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J. Infect. Dis. 198:1131-1140.
52. Stock, S. J., et al. 2009. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod. Sci. 16:1125-1134.
53. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
54. Tamura, K., M. Nei, and S. Kumar. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U. S. A. 101:11030-11035.
55. Tien, M. T., et al. 2006. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176:1228- 1237.
56. Turnbaugh, P. J., et al. 2007. The human microbiome project. Nature 449: 804-810.
57. Westrom, L., G. Evaldson, and K. K. Holmes. 1984. Taxonomy of vaginosis: bacterial vaginosis-a definition. Scand. J. Urol. Nephrol. Suppl. 86:259-264.
58. Yeoman, C. J., et al. 2010. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 5:e12411.
59. Zhu, T., et al. 1998. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391:594-597.